ACONW

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-920 ExitQ1 2025 $920 $0.0534 $0.0299
Ken GriffinCitadel Advisors $-368 TrimQ4 2024 $368 $0.0303 $0.0299

Trade ACONW

About Aclarion, Inc.

Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.

CEO: Brent Ness
IPO Date: Apr 22, 2022

Market Data

Open: $0.0265
High: $0.0292
Low: $0.0265
Volume: 4.5K
52W High: $0.048
52W Low: $0.0279

Valuation

Market Cap: $16k
Enterprise Value: $-17M

Financials

Free Cash Flow: $-7.2M
Revenue: $76k
Net Income: $-7.2M
Cash: $12M
Debt: $0

Events

EarningsAug 28

EPS est. -1.05